Molly Gibson, PhD is an experienced founder, technologist, and builder of AI-native platforms that expand the boundaries of scientific discovery. Today, Molly serves as co-founder and president of Future Science at Lila, a company building the world’s first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences. As a co-founder and Chief Strategy & Innovation Officer at Generate:Biomedicines, she led the development of one of the world’s first transformer-based models for protein design — pioneering a new approach to therapeutic creation through generative AI.